Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired Paxlovid labeled for emergency use to patients through March 8, after which Paxlovid labeled for emergency use must be returned to the manufacturer or disposed of in accord with regulations, the agency said.

The FDA last May approved a new drug application for Pfizer’s Paxlovid to treat adults at high risk of progressing to severe COVID-19. Paxlovid labeled under the new drug application will continue to be authorized for emergency use to treat eligible pediatric patients, the agency said.
 

Headline
The Wisconsin Department of Health Services announced Nov. 13 that a second child in the state died of measles amid its ongoing outbreak. As of Nov. 13, the…
Headline
Pennsylvania has recorded its seventh measles-associated death this year as a statewide outbreak of the virus continues, according to an update Nov. 13 by the…
Headline
The Wisconsin Department of Health Services reported Nov. 5 that an infant died of measles, marking the first measles-associated death in the state since 1990.…
Headline
The New York State Department of Health announced Nov. 2 that a child died of measles amid the state’s ongoing outbreak and is the first known measles…
Headline
There have been 1,398 confirmed cases of measles in Pennsylvania this year, according to data released Oct. 28 by the Pennsylvania Department of Health. Data…
Headline
The Centers for Disease Control and Prevention reported 798 laboratory-confirmed flu-associated hospitalizations for the week ending Oct. 17. The weekly…